Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar, Katherine K. Perez, Madiha Ashraf, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 8, pp. 1680-1690
Open Access | Times Cited: 285

Showing 1-25 of 285 citing articles:

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Victoria A. Avanzato, M. Jeremiah Matson, Stephanie N. Seifert, et al.
Cell (2020) Vol. 183, Iss. 7, pp. 1901-1912.e9
Open Access | Times Cited: 738
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 1015-1027
Open Access | Times Cited: 513
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Sean Liu, Hung-Mo Lin, Ian Baine, et al.
Nature Medicine (2020) Vol. 26, Iss. 11, pp. 1708-1713
Open Access | Times Cited: 469
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
Michael J. Joyner, Jonathon W. Senefeld, Stephen A. Klassen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 357
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
Emerging treatment strategies for COVID-19 infection
Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Eleni Korompoki, et al.
Clinical and Experimental Medicine (2020) Vol. 21, Iss. 2, pp. 167-179
Open Access | Times Cited: 316
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Qianqian Zhang, Rong Xiang, Shanshan Huo, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 300
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Cheol-Min Kim, Dong-Kyun Ryu, Jihun Lee, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 276
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
William N. Voss, Yixuan J. Hou, Nicole V. Johnson, et al.
Science (2021) Vol. 372, Iss. 6546, pp. 1108-1112
Open Access | Times Cited: 265
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Xiangyu Chen, Zhiwei Pan, Shuai Yue, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 245
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
Eric Salazar, Paul Christensen, Edward A. Graviss, et al.
American Journal Of Pathology (2020) Vol. 190, Iss. 11, pp. 2290-2303
Open Access | Times Cited: 236
Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
Eric Salazar, Suresh V. Kuchipudi, Paul A. Christensen, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6728-6738
Open Access | Times Cited: 192
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Claire Iannizzi, Khai Li Chai, et al.
Cochrane library (2021) Vol. 2021, Iss. 5
Open Access | Times Cited: 188
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Eric Salazar, Paul Christensen, Edward A. Graviss, et al.
American Journal Of Pathology (2020) Vol. 191, Iss. 1, pp. 90-107
Open Access | Times Cited: 151
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
Michael Joyce, Wei‐Hung Chen, Rajeshwer S. Sankhala, et al.
Cell Reports (2021) Vol. 37, Iss. 12, pp. 110143-110143
Open Access | Times Cited: 149
Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
Miquéias Lopes‐Pacheco, Pedro Leme Silva, Fernanda F. Cruz, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 146
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Carmen Riggioni, Pasquale Comberiati, Mattia Giovannini, et al.
Allergy (2020) Vol. 75, Iss. 10, pp. 2503-2541
Open Access | Times Cited: 141
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Khai Li Chai, Sarah J Valk, Vanessa Piechotta, et al.
Cochrane library (2020)
Open Access | Times Cited: 138
Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes
Jana L. Jacobs, William Bain, Asma Naqvi, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 9, pp. 1525-1533
Open Access | Times Cited: 121
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
Savannah E. Butler, Andrew R. Crowley, Harini Natarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 115
Convalescent Plasma Therapy for COVID-19: State of the Art
Daniele Focosi, Arthur O. Anderson, Julian W. Tang, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 126
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
Luoping Zhang, Helen Guo
Advances in Biomarker Sciences and Technology (2020) Vol. 2, pp. 1-23
Open Access | Times Cited: 112
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
Sarah E. Benner, Eshan U. Patel, Oliver Laeyendecker, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. 12, pp. 1974-1984
Open Access | Times Cited: 112
Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy
Michael J. Joyner, Stephen A. Klassen, Jonathon W. Senefeld, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 89
COVID-19 Therapeutic Options Under Investigation
Malak Kaddoura, Malak Al Ibrahim, Ghina Hijazi, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 83
Page 1 - Next Page

Scroll to top